| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.3M | +478.2% |
| R&D Expense | $187.7M | -24.7% |
| SG&A Expense | $90.2M | +67.8% |
| Operating Income | -$267.6M | +11.2% |
| Interest Expense | $1.3M | -35.2% |
| Pre-tax Income | -$277.7M | +8.4% |
| Income Tax | $0 | — |
| Net Income | -$279.8M | +7.9% |
| EPS (Basic) | -$1.17 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.3M | -34.9% |
| Short-term Investments | $206.7M | -37.4% |
| Accounts Receivable | $1.7M | -68.9% |
| Current Assets | $315.2M | -29.7% |
| Total Assets | $348.5M | -29.7% |
| Current Liabilities | $96.9M | +47.3% |
| Total Liabilities | $126.2M | +31.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$216.2M | -0.2% |
| Capital Expenditures | $969K | -21.3% |
| Investing Cash Flow | $109.6M | +162.5% |
| Financing Cash Flow | $81.8M | -61.3% |
| Free Cash Flow | -$217.2M | -0.1% |
| +19.3% |
| EPS (Diluted) | -$1.17 | +19.3% |
| Stockholders' Equity |
| $222.4M |
| -44.4% |